Correlation Between RA Medical and Vivos Therapeutics
Can any of the company-specific risk be diversified away by investing in both RA Medical and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RA Medical and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RA Medical Systems and Vivos Therapeutics, you can compare the effects of market volatilities on RA Medical and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RA Medical with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RA Medical and Vivos Therapeutics.
Diversification Opportunities for RA Medical and Vivos Therapeutics
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RMED and Vivos is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding RA Medical Systems and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and RA Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RA Medical Systems are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of RA Medical i.e., RA Medical and Vivos Therapeutics go up and down completely randomly.
Pair Corralation between RA Medical and Vivos Therapeutics
If you would invest 321.00 in Vivos Therapeutics on October 11, 2024 and sell it today you would earn a total of 116.00 from holding Vivos Therapeutics or generate 36.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 2.44% |
Values | Daily Returns |
RA Medical Systems vs. Vivos Therapeutics
Performance |
Timeline |
RA Medical Systems |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vivos Therapeutics |
RA Medical and Vivos Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RA Medical and Vivos Therapeutics
The main advantage of trading using opposite RA Medical and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RA Medical position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.RA Medical vs. SINTX Technologies | RA Medical vs. ReShape Lifesciences | RA Medical vs. Bone Biologics Corp | RA Medical vs. Tivic Health Systems |
Vivos Therapeutics vs. Bone Biologics Corp | Vivos Therapeutics vs. Tivic Health Systems | Vivos Therapeutics vs. Bluejay Diagnostics | Vivos Therapeutics vs. Rapid Micro Biosystems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |